1. Home
  2. SVRA vs LZB Comparison

SVRA vs LZB Comparison

Compare SVRA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Savara Inc.

SVRA

Savara Inc.

N/A

Current Price

$5.05

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

N/A

Current Price

$29.44

Market Cap

1.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
SVRA
LZB
Founded
2007
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
SVRA
LZB
Price
$5.05
$29.44
Analyst Decision
Strong Buy
Buy
Analyst Count
8
2
Target Price
$10.94
★ $41.00
AVG Volume (30 Days)
★ 1.5M
629.9K
Earning Date
11-11-2026
11-17-2026
Dividend Yield
N/A
★ 3.27%
EPS Growth
N/A
★ 5.11
EPS
N/A
★ N/A
Revenue
N/A
★ $2,349,433,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3,963.52
$3.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.34
$28.92
52 Week High
$7.01
$44.90

Technical Indicators

Market Signals
Indicator
SVRA
LZB
Relative Strength Index (RSI) 45.29 29.02
Support Level $5.16 N/A
Resistance Level $5.49 $36.50
Average True Range (ATR) 0.22 0.74
MACD -0.01 0.20
Stochastic Oscillator 45.11 8.60

Price Performance

Historical Comparison
SVRA
LZB

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.

Share on Social Networks: